0000315066-16-005625.txt : 20160218
0000315066-16-005625.hdr.sgml : 20160218
20160218140038
ACCESSION NUMBER: 0000315066-16-005625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160217
FILED AS OF DATE: 20160218
DATE AS OF CHANGE: 20160218
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001445283
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-225-0096
MAIL ADDRESS:
STREET 1: 200 TECHNOLOGY SQUARE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC
DATE OF NAME CHANGE: 20080916
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FMR LLC
CENTRAL INDEX KEY: 0000315066
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37695
FILM NUMBER: 161437037
BUSINESS ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6175706339
MAIL ADDRESS:
STREET 1: 245 SUMMER STREET
CITY: BOSTON
STATE: MA
ZIP: 02210
FORMER NAME:
FORMER CONFORMED NAME: FMR CORP
DATE OF NAME CHANGE: 19920717
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2016-02-17
1
0001445283
PROTEOSTASIS THERAPEUTICS, INC.
PTI
0000315066
FMR LLC
245 SUMMER STREET
BOSTON
MA
02210
0
0
0
1
See Remark 1
Common Stock
2016-02-17
4
C
0
925051
A
1318932
I
F-Prime Capital Partners Healthcare Fund II LP
Common Stock
2016-02-17
4
C
0
183880
A
1502812
I
F-Prime Capital Partners Healthcare Fund II LP
Common Stock
2016-02-17
4
P
0
375000
8
A
1877812
I
F-Prime Capital Partners Healthcare Fund II LP
Series A Convertible Preferred Stock
2016-02-17
4
C
0
10000000
D
Common Stock
925051
0
I
F-Prime Capital Partners Healthcare Fund II LP
Series B Convertible Preferred Stock
2016-02-17
4
C
0
1987782
D
Common Stock
183880
0
I
F-Prime Capital Partners Healthcare Fund II LP
On February 17, 2016, in connection with the completion of the issuer's initial public offering, all shares of Convertible Preferred Stock converted into shares of Common Stock at a 10.8102-for-one conversion ratio.
Includes 393,881 shares of Common Stock issued as payment of accrued dividends upon conversion of the Series A Convertible Preferred Stock on February 17, 2016.
Remark 1: Abigail P. Johnson is a Director, the Vice Chairman, the Chief Executive Officer and the President of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders have entered into a shareholders' voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders' voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. The address of Abigail P. Johnson is c/o FMR LLC, 245 Summer Street, Boston, MA 02110.
Remark 2: The general partner of F-Prime Capital Partners Healthcare Fund II LP is F-Prime Capital Partners Healthcare Advisors Fund II LP. F-Prime Capital Partners Healthcare Advisors Fund II LP is solely managed by Impresa Management LLC, its general partner and investment manager. Impresa Management LLC is owned, directly or indirectly, by various shareholders and employees of FMR LLC, including certain members of the Johnson family.
Exhibit List: Exhibit 24 - Powers of Attorney.
Daniel T. Gallagher, Duly authorized under Powers of Attorney, by and on behalf of FMR LLC and its direct and indirect subsidiaries and Abigail P. Johnson
2016-02-18
EX-24
2
exhibit24poa.txt
EX-24 DOCUMENT
POWER OF ATTORNEY
WHEREAS, FMR LLC ("FMR") has appointed Marc R. Bryant, with full power of
substitution, as its true and lawful attorney, with full power and authority to
execute such documents and to make such regulatory or other filings and
amendments thereto (the "Filings") as shall from time to time be required
pursuant to the Securities Exchange Act of 1934, as amended, any rules or
regulations adopted thereunder, and such other U.S. and non-U.S. laws, rules
or regulations as shall from time to time be applicable in respect of the
beneficial ownership of securities directly or indirectly attributable to FMR
and its direct and indirect subsidiaries, and generally to do all such things
in its name and on its behalf in connection therewith as said attorney-in-fact
deems necessary or appropriate to cause such filings to be completed and filed.
NOW, THEREFORE, the undersigned hereby constitutes and apppoints
Daniel T. Gallagher as his substitute, to have all the powers of the undersigned
with respect to the Filings, when the undersigned is unavailable.
The Power of Attorney shall remain in full force and effect only
for such time as the undersigned shall continue to be an officer of Fidelity
Management & Research Company, provided that, notwithstanding the foregoing,
this Power of Attorney may be revoked at any time by the undersigned in writing.
/s/ Marc R. Bryant
Marc R. Bryant
Dated: November 30, 2015
POWER OF ATTORNEY
WHEREAS, Abigail P. Johnson has appointed Scott C. Goebel, with full
power of substitution, as her true and lawful attorney, with full power and
authority to execute such documents and to make such regulatory or other filings
and amendments thereto (the "Filings") as shall from time to time be required
pursuant to the Securities Exchange Act of 1934, as amended, any rules or
regulations adpoted thereunder, and such other U.S. and non-U.S. laws, rules
or regulations as shall from time to time be applicable in respect of the
beneficial ownership of securities directly or indirectly attributable to her.
NOW, THEREFORE, the undersigned hereby constitutes and appoints
Daniel T. Gallagher as his substitute, to have all the powers of the
undersigned with respect to the Filings, when the undersigned is unavailable.
The Power of Attorney shall remain in full force and effect only
for such time as the undersigned shall continue to be an officer of Fidelity
Management & Research Company, provided that, notwithstanding the foregoing,
this Power of Attorney may be revoked at any time by the undersigned in writing.
/s/ Scott C. Goebel
Scott C. Goebel
Dated: June 18, 2014